Branhamella catarrhalis: Epidemiological and clinical aspects of a human respiratory tract pathogen

Thorax

Volumn 53, Issue 2, 1998, Pages 124-128

  Murphy, Timothy F ^a,b,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^c Medical Research 151   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PNEUMONIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; HOSPITAL INFECTION; HUMAN; MORAXELLA CATARRHALIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SEASONAL VARIATION; ADULT; AGED; CROSS INFECTION; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEWBORN; PREVALENCE; SEASON;

ANTIINFECTIVE AGENT;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CROSS INFECTION; HUMANS; INFANT; INFANT, NEWBORN; LUNG DISEASES, OBSTRUCTIVE; MORAXELLA (BRANHAMELLA) CATARRHALIS; PNEUMONIA, BACTERIAL; PREVALENCE; RESPIRATORY TRACT INFECTIONS; SEASONS;

EID: 0031898531     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.2.124     Document Type: Review

References (71)

1. Murphy TF. Branhamella catarrhalis: epidemiology, surface antigenic structure and immune response. Microbiol Rev 1996;60:267-79.
2. Ghon A, Pfeiffer H. Der Micrococcus catarrhalis (R. Pfeiffer) als Krankheitserreger. Z Klin Med 1902;44:263-81.
3. Berk SL. From Micrococcus to Moraxella - the reemergence of Branhamella catarrhalis. Arch Intern Med 1990;150:2254-7.
4. Catlin BW. Transfer of the organism named Neisseria catarrhalis to Branhamella genus. Int J Syst Bacteriol 1970; 20:155-9.
5. Bovre K. Proposal to divide the genus Moraxella into two subgenera, subgenus Moraxella and subgenus Branhamella. Int J Syst Bacteriol 1979;29:403-6.
6. Catlin BW. Branhamaceae fem. nov., a proposed family to accommodate the genera Branhamella and Moraxella. Int J Syst Bacteriol 1991;41:320-3.
7. Catlin BW. Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin Microbiol Rev 1990;3:293-320.
8. Smith GL. Branhamella catarrhalis infection imitating gonorrhea in a man. N Engl J Med 1987;316:1277.
9. Doern GV, Gantz NM. Isolation of Branhamella (Neisseria) catarrhalis from men with urethritis. Sex Transm Dis 1982; 9:202-4.
10. Vaneechoutte M, Verschraegen G, Claeys G, Weise B, Van Den Abeele AM. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M catarrhalis from sputum. J Clin Microbiol 1990;28:2674-80.
11. Pollard JA, Wallace RJ Jr, Nash DR, Luman JI, Wilson RW. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease. Drugs 1986;31:103-8.
12. Ejlertsen T, Thisted E, Ebbesen F, Olesen B, Renneberg J. Branhamella catarrhalis in children and adults. A study of prevalence, time of colonisation, and association with upper and lower respiratory tract infections. J Infect 1994; 29:23-31.
13. Jousimies-Somer HR, Savolainen S, Ylikoski JS. Comparison of the nasal bacterial floras in two groups of healthy subjects and in patients with acute maxillary sinusitis. J Clin Microbiol 1989;27:2736-43.
14. Van Hare GF, Shurin PA, Marchant CD, et al. Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis 1987;9:16-27.
15. Faden H, Harabuchi Y, Hong JJ. Tonawanda/Williamsville Pediatrics. Epidemiology of Moraxella catarrhalis in children during the first two years of life: relationship to otitis media. J Infect Dis 1994;169:1312-7.
16. Aniansson G, Alm B, Andersson B, et al. Nasopharyngeal colonisation during the first year of life. J Infect Dis 1992; 165(Suppl 1):S38-42.
17. Lundgren K, Ingvarsson L. Acute otitis media in Sweden. Role of Branhamella catarrhalis and the rationale for choice of antimicrobial therapy. Drugs 1986;31:125-31.
18. Smith JMB, Lockwood BM. A 2-year survey of Branhamella catarrhalis in a general hospital. J Hosp Infect 1986;7: 277-82.
19. Boyle FM, Georghiou PR, Tilse MH, McCormack JG. Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections. Med J Aust 1991;154: 592-6.
20. Klingman KL, Pye A, Murphy TF, Hill SL. Dynamics of respiratory tract colonization by Moraxella (Branhamella) catarrhalis in bronchiectasis. Am J Respir Crit Care Med 1995;152:1072-8.
21. Davies BI, Maesen FPV. Epidemiological and bacteriological findings on Branhamella catarrhalis respiratory infections in The Netherlands. Drugs 1986;31:28-33.
22. Verghese A, Berk SL. Moraxella (Branhamella) catarrhalis. Infect Dis Clin North Am 1991;5:523-38.
23. Wright PW, Wallace RJ Jr, Shepherd JR. A descriptive study of 42 cases of Branhamella catarrhalis pneumonia. Am J Med 1990;88(5A):2S-8S.
24. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;146: 1067-83.
25. Chapman AJ, Musher DM, Jonsson S, Clarridge JE, Wallace RJ. Development of bactericidal antibody during Branhamella catarrhalis infection. J Infect Dis 1985;151:878-82.
26. Nicotra B, Rivera M, Luman JI, Wallace RJ. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch Intern Med 1986;146: 890-3.
27. Srinivasan G, Raff MJ, Templeton WC, Givens SJ, Graves RC, Melo JC. Branhamella catarrhalis pneumonia. Report of two cases and review of the literature. Am Rev Respir Dis 1981;123:553-5.
28. von Graevenitz A, Rathbone RR. Branhamella catarrhalis in respiratory secretions: clinical correlation in 16 cases. South Med 1981;74:1095-6.
29. McLeod DT, Ahmad F, Capewell S, Croughan MJ, Calder MA, Seaton A. Increase in bronchopulmonary infection due to Branhamella catarrhalis. BMJ 1986;292:1103-5.
30. Hager H, Verghese A, Alvarez S, Berk SL. Branhamella catarrhalis respiratory infections. Rev Infect Dis 1987;9: 1140-9.
31. Ninane G, Joly J, Kraytman M. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture. BMJ 1978;1:276-8.
32. West M, Berk SL, Smith JK. Branhamella catarrhalis pneumonia. South Med J 1982;75:1021-3.
33. Aitken JM, Thornley PK. Isolation of Branhamella catarrhalis from sputum and tracheal aspirate. J Clin Microbiol 1983; 18:1262-3.
34. Doern GV, Miller MJ, Winn RE. Branhamella (Neisseria) catarrhalis systemic disease in humans. Arch Intern Med 1981;141:1690-2.
35. Choo PW, Gantz NM. Branhamella catarrhalis pneumonia with bacteremia. South Med J 1989;82:1317-8.
36. Wallace MR, Oldfield EC III. Moraxella (Branhamella) catarrhalis bacteremia. Arch Intern Med 1990;150:1332-4.
37. Collazos J, de Miguel J, Ayarza R. Moraxella catarrhalis bacteremic pneumonia in adults: two cases and review of the literature. Eur J Clin Microbiol Infect Dis 1992;11: 237-40.
38. Ioannidis JPA, Worthington M, Griffiths JK, Snydman DR. Spectrum and significance of bacteremia due to Moraxella catarrhalis. Clin Infect Dis 1995;21:390-7.
39. Verghese A, Roberson D, Kalbfleisch JH, Sarubbi F. Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis. Antimicrob Agents Chemother 1990;34:1041-4.
40. Carr B, Walsh JB, Coakley D, Mulvihill E, Keane C. Prospective hospital study of community acquired lower respiratory tract infection in the elderly. Respir Med 1991; 85:185-7.
41. Barreiro B, Esteban L, Prats E, Verdaguer E, Dorca J, Manresa F. Branhamella catarrhalis respiratory infections. Eur Respir J 1992;5:675-9.
42. Ahmad F, McLeod DT, Power JT, Calder MA. Branhamella catarrhalis prevalence in a hospital population. J Hosp Infect 1985;6:71-4.
43. Haddad J, Le Faou A, Simeoni U, Messer J. Hospital-acquired bronchopulmonary infection in premature infants due to Branhamella catarrhalis. J Hosp Infect 1986;7: 301-2.
44. Hiroshi S, Anaissie EJ, Khardori N, Bodey GP. Branhamella catarrhalis septicemia in patients with leukemia. Cancer 1988;61:2315-7.
45. Patterson TF, Patterson JE, Masecar BL, Barden GE, Hierholzer WJ Jr, Zervos MJ. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. J Infect Dis 1988;157:996-1001.
46. Cook PP, Hecht DW, Snydman DR. Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: risk factors for disease. J Hosp Infect 1989;13:299-307.
47. Patterson JE, Patterson TF, Farrel P, Hierholzer WJ Jr, Zervos MJ. Evaluation of restriction endonuclease analysis as an epidemiologic typing system for Branhamella catarrhalis. J Clin Microbiol 1989;27:944-6.
48. Gray LD, Van Scoy RE, Anhalt JP, Yu PKW. Wound infection caused by Branhamella catarrhalis. J Clin Microbiol 1989;27:818-20.
49. Picard B, Goullet Ph, Denamur E, Suerdmondt G. Esterase electrophoresis: a molecular tool for studying the epidemiology of Branhamella catarrhalis nosocomial infection. Epidemiol Infect 1989;103:547-54.
50. Robert MC, Pang Y, Spencer RC, Winstanley TG, Brown BA, Wallace RJ Jr. Tetracycline resistance in Moraxella (Branhamella) catarrhalis: demonstration of two clonal outbreaks by using pulsed-field gel electrophoresis. Antimicrob Agents Chemother 1991;35:2453-5.
51. McKenzie H, Morgan MG, Jordens JZ, Enright MC, Bain M. Characterisation of hospital isolates of Moraxella (Branhamella) catarrhalis by SDS-PAGE of whole-cell proteins, immunoblotting and restriction-endonuclease analysis. J Med Microbiol 1992;37:70-6.
52. Morgan MG, McKenzie H, Enright MC, Bain M, Emmanuel FXS. Use of molecular methods to characterise Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection. Eur J Clin Microbiol Infect Dis 1992; 11:305-12.
53. Beaulieu D, Scriver S, Bergeron MG, et al. Epidemiological typing of Moraxella catarrhalis by using DNA probes. J Clin Microbiol 1993;31:736-9.
54. Richards SJ, Greening AP, Enright MC, Morgan MG, McKenzie H. Outbreak of Moraxella catarrhalis in a respiratory unit. Thorax 1993;48:91-2.
55. Ikram RB, Nixon M, Aitken J, Wells E. A prospective study of isolation of Moraxella catarrhalis in a hospital during the winter months. J Hosp Infect 1993;25:7-14.
56. Kawakami Y, Ueno I, Katsuyama T, Furihata K, Matsumoto H. Restriction fragment length polymorphism (RFLP) of genomic DNA of Moraxella (Branhamella) catarrhalis isolates in a hospital. Microbiol Immunol 1994;38:891-5.
57. Wright PW, Wallace RJ Jr. Pneumonia due to Moraxella (Branhamella) catarrhalis. Semin Respir Infect 1989;4:40-6.
58. Ainsworth SM, Nagy SB, Morgan LA, Miller GR, Perry JL. Interpretation of gram-stained sputa containing Moraxella (Branhamella) catarrhalis. J Clin Microbiol 1990;28:2559-60.
59. Speeleveld E, Fossepre J-M, Gordts B, Van Landuyt HW. Comparison of three rapid methods, tributyrine, 4-methyl-umbelliferyl butyrate, and indoxyl acetate, for rapid identification of Moraxella catarrhalis. J Clin Microbiol 1994; 32:1362-3.
60. Barbe G, Babolat M, Boeufgras JM, Monget D, Freney J. Evaluation of API NH, a new 2-hour system for identification of Neisseria and Haemophilus species and Moraxella catarrhalis in a routine clinical laboratory. J Clin Microbiol 1994;32:187-9.
61. Janda WM, Zigler KL, Bradna JJ, API quadFERM + rapid DNase for identification of Neisseria spp. and Branhamella catarrhalis. J Clin Microbiol 1987;25:203-6.
62. Hughes B, Pezzlo MT, De La Maza L, Peterson EM. Rapid identification of pathogenic Neisseria species and Branhamella catarrhalis. J Clin Microbiol 1987;25:2223-4.
63. Janda WM, Ruther P. B.CAT CONFIRM, a rapid test for confirmation of Branhamella catarrhalis. J Clin Microbiol 1989;27:1130-1.
64. Dealler SF, Abbott M, Croughan MJ, Hawkey PM. Identification of Branhamella catarrhalis in 2.5 min with an indoxyl hutyrate strip test. J Clin Microbiol 1989;27:1390-1.
65. Gillespie SH, Ullman C, Smith MD, Emery V. Detection of Streptococcus pneumoniae in sputum samples by PCR. J Clin Microbiol 1994;32:1308-11.
66. Post JC, Preston RA, Aul JJ, et al. Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA 1995;273:1598-604.
67. Barry AL, Pfaller MA, Fuchs PC, Packer RR. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob Agents Chemother 1994;38:2419-25.
68. Fung CP, Powell M, Seymour A, Yuan M, Williams JD. The antimicrobial susceptibility of Moraxella catarrhalis isolated in England and Scotland in 1991. J Antimicrob Chemother 1992;30:47-55.
69. Powell M, McVey D, Kassim MH, Chen HY, Williams JD. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa. J Antimicrob Chemother 1991;28:249-59.
70. Doern GV, Siebers KG, Hallick LM. Antibiotic susceptibility of β-lactamase-producing strains of Branhamella (Neisseria) catarrhalis. Antimicrob Agents Chemother 1984; 26:424-5.
71. Fung C-P, Yeo S-F, Livermore DM. Susceptibility of Moraxella catarrhalis isolates to β-lactam antibiotics in relation to β-lactamase pattern. J Antimicrob Chemother 1994;33: 215-22.